• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

367
66
48
46
21

COUNTRY

45
12
6
5
5

PRICE

300
551
972
1,404

PUBLISHED

0
108
467
1,404

PRODUCT TYPE

1,309
67
17
11

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Bayer Aspirin Protect-Drug Insights,2014 Bayer Aspirin Protect-Drug Insights,2014 - Product Thumbnail Image

Bayer Aspirin Protect-Drug Insights,2014

“Bayer Aspirin Protect - Drug Insights, 2014” provides Bayer Aspirin Protect marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

October 2014
FROM
Invega Sustenna/Xeplion-Drug Insights,2014 Invega Sustenna/Xeplion-Drug Insights,2014 - Product Thumbnail Image

Invega Sustenna/Xeplion-Drug Insights,2014

“Invega Sustenna/Xeplion - Drug Insights, 2014” provides Invega Sustenna/Xeplion marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales...

October 2014
FROM
Xeristar-Drug Insights,2014 Xeristar-Drug Insights,2014 - Product Thumbnail Image

Xeristar-Drug Insights,2014

“Xeristar - Drug Insights, 2014” provides Xeristar marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

October 2014
FROM
Xarelto-Drug Insights,2014 Xarelto-Drug Insights,2014 - Product Thumbnail Image

Xarelto-Drug Insights,2014

“Xarelto - Drug Insights, 2014” provides Xarelto marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

October 2014
FROM

Neurological Research

10 issues per year Neurological Research is an international, peer-reviewed journal for reporting both basic and clinical research in the fields of neurosurgery, neurology, neuroengineering and neurosciences...

October 2014
FROM

Nutritional Neuroscience

"6 issues per year (Online Only) Nutritional Neuroscience is an international, interdisciplinary broad-based journal for reporting both basic and clinical research in the field of nutrition that relates...

October 2014
FROM

Neurotech Business Report

Neurotech Business Report is the first publication targeting the business of neurotechnology, the application of engineering techniques to human neural and information processing systems Each monthly...

October 2014
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

October 2014
FROM

Partial Seizure - Pipeline Review, H2 2014

Partial Seizure - Pipeline Review, H2 2014 Summary This, ‘Partial Seizure - Pipeline Review, H2 2014’, provides an overview of the Partial Seizure’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing...

September 2014
FROM

Autism - Pipeline Review, H2 2014

Autism - Pipeline Review, H2 2014 Summary This, ‘Autism - Pipeline Review, H2 2014’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM

Cognitive Impairment - Pipeline Review, H2 2014

Cognitive Impairment - Pipeline Review, H2 2014 Summary This, ‘Cognitive Impairment - Pipeline Review, H2 2014’, provides an overview of the Cognitive Impairment’s therapeutic pipeline. This report...

September 2014
FROM

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014 Summary This, ‘Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2014’, provides an overview of the Attention...

September 2014
FROM

Cancer Pain - Pipeline Review, H2 2014

Cancer Pain - Pipeline Review, H2 2014 Summary This, ‘Cancer Pain - Pipeline Review, H2 2014’, provides an overview of the Cancer Pain’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014

Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014 Summary This, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2014’, provides an overview of the Bipolar Disorder (Manic Depression)’s...

September 2014
FROM

Multiple Sclerosis - Pipeline Review, H2 2014

Multiple Sclerosis - Pipeline Review, H2 2014 Summary This, ‘Multiple Sclerosis - Pipeline Review, H2 2014’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

September 2014
FROM

Cerebral Palsy - Pipeline Review, H2 2014

Cerebral Palsy - Pipeline Review, H2 2014 Summary This, ‘Cerebral Palsy - Pipeline Review, H2 2014’, provides an overview of the Cerebral Palsy’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014

Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014 Summary This, ‘Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2014’, provides an overview of the Relapsing Multiple Sclerosis...

September 2014
FROM

Sedation - Pipeline Review, H2 2014

Sedation - Pipeline Review, H2 2014 Summary This, ‘Sedation - Pipeline Review, H2 2014’, provides an overview of the Sedation’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Dystonia - Pipeline Review, H2 2014

Dystonia - Pipeline Review, H2 2014 Summary This, ‘Dystonia - Pipeline Review, H2 2014’, provides an overview of the Dystonia’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM
Loading Indicator

Our Clients

Our clients' logos